๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Refractory anemia with excess of blasts in transformation hematologic and clinical study of 52 patients

โœ Scribed by Sheryl D. Michels; Jean Saumur; Diane C. Arthur; Leslie L. Robison; Richard D. Brunning

Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
680 KB
Volume
64
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Low dose cytosine arabinoside in refract
Low dose cytosine arabinoside in refractory anemia with excess of blasts in transformation
โœ Fridrik, M. A. ;Wahl, G. ;Herbinger, W. ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer-Verlag โš– 352 KB

Myelodysplastic syndromes (MDS) are heterogeneous diseases. Patients with blast counts of more than 20% of nucleated bone marrow cells have a high risk of short survival. We treated six patients with refractory anemia with excess of blast in transformation (RAEBiT) with low dose cytosine arabinoside

Analysis of prognostic factors in patien
Analysis of prognostic factors in patients with refractory anemia with excess of blasts (RAEB) reclassified according to WHO proposal
โœ M. Breccia; R. Latagliata; L. Cannella; I. Carmosino; R. De Cuia; A. Frustaci; C ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 88 KB

The WHO classification subdivides the FAB RAEB category into RAEB-1 (bone marrow (BM) blasts <10%, peripheral blasts <5%) and RAEB-2 (bone marrow blasts >10% and peripheral blasts >5%). We reclassified according to WHO criteria 228 RAEB patients and analysed them in terms of haematological, karyotyp